Tumors Services For Medical Specialties
-
Manufactured by XILIS, Inc.based in USA
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS can be used in large-scale pharmacogenomic studies that are ...
-
Manufactured by Elpisciencebased in CHINA
Elpiscience leverages our deep understanding of tumor biology and mechanisms of action to translate target biology for challenging pathways, develop biomarkers and strategically select indications and patients for clinical studies. We apply cutting-edge technologies including gene editing for target screening, single cell sequencing and advanced bioinformatics with over 1,000 tumor organoid ...
-
Manufactured by Alfa Chemistrybased in USA
Nimustine hydrochloride can alkylate and cross-link DNA, which induces DNA replication blockade and DNA double-strand breaks, leading to the failure of DNA synthesis. In this way, nimustine hydrochloride exerts an anti-tumor effect, especially on malignant brain tumors. Alfa Chemistry offers high quality nimustine hydrochloride. Please feel free to contact us for APIs or technical ...
-
Manufactured by Immatics N.V.based in GERMANY
Immatics’ latest proprietary ACTengine® manufacturing processes are designed to generate cell product candidates within a short manufacturing window and deliver highly proliferative T cells, with the capability to infiltrate the patient’s tumor and function in a challenging solid tumor microenvironment. Immatics is actively investigating multiple next-generation enhancement ...
-
Manufactured by BiomXbased in ISRAEL
Our colorectal cancer program utilizes engineered phage with various payloads (such as immunostimulatory payloads) that are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. The aim of payload delivery is to convert cold tumors to hot tumors with activated immune responses. ...
-
based in USA
Tissue500™ is a comprehensive genomic profiling test that detects clinically relevant mutations in 572 genes to identify a patient’s unique cancer ...
-
Manufactured by Creative Biolabsbased in CHINA
γδ T cells are a distinct subgroup of T cells containing T cell receptors (TCRs) γ and TCR δ chains. Compared to αβ T cells, γδ T cells without MHC restriction on tumor antigen recognition have strong cytotoxic effects on tumor cells. γδ T cells have been considered as wonderful effector cells for cancer immunotherapy. Creative Biolabs is an excellent expert in γδ T cell research and γδ T cell ...
-
Manufactured by Foundation Medicine, Inc.based in USA
Discover tissue AND blood-based FDA-approved comprehensive genomic profiling testing for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for hematologic malignancies, sarcomas, or solid tumors where fusion detection is desired. ...
-
Manufactured by SAGA Diagnostics ABbased in SWEDEN
In direct comparisons, ctDNA has been shown to be superior to conventional serum protein biomarkers, circulating tumor cells, and radiographic imaging. Analysis of ctDNA in liquid biopsies is rapidly becoming one of the most important minimally invasive diagnostic methods used in oncology since it has overcome the many limitations of traditional diagnostic methods used ...
-
based in USA
For rapid and precise cancer care, pathologists and oncologists need dependable diagnostic testing to connect patients to individualized immuno-oncology therapies. Flagship’s TissueInsight® diagnostic service offers you access to robust, contextual data for advanced patient care. Our exclusive, targeted testing in our CAP/CLIA lab provides the most accurate and precise tissue scoring ...
-
Manufactured by Veracytebased in FRANCE
From our proprietary biomarkers, our innovated assays solutions, our unique data analysis platforms and our CDx development capabilities, we offer a comprehensive family of biomarker services that enhance your insight into the tumor microenvironment ...
-
Manufactured by MedGenome Inc.based in USA
Detailed RNA specific QC reports. Differential expression analysis. Pathway enrichment analysis. Fusion and splicing event analysis with interactive genome browser to visualize results. Proprietary tumor microenvironment ...
-
based in USA
Champions Oncology's ex vivo 3D co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Immuno-Oncology researchers the ability to test their therapeutics in a 3D organoid assay that can mimic mechanism of action. The Autologous TIL platform is an ex vivo 3D co-culture platform developed and optimized to interrogate the ...
-
based in USA
We routinely run assays with primary cells and iPSC-derived cells. Organ models: liver, brain, blood and tumors. Normal tissue models: 3D cell-based culture and co-culture models. Tumors: lung, breast, liver etc. We can test small molecules and biologics with tissue slices, and organoids, and maintain cell diversity in the unaltered patient tissue. Cell-based assays are run in our proprietary ...
-
Manufactured by ITM Isotope Technologies Munich SEbased in GERMANY
Targeted Radionuclide Therapy (TRT) or Peptide Receptor Radionuclide Therapy (PRRT) is a medical specialty using very small amounts of radioactive compounds, called radiopharmaceuticals, to diagnose and treat various diseases, like cancer. Once injected into the patient, the radiopharmaceutical finds its way to the tumor through the bloodstream and binds to the tumor specific receptor according ...
-
based in USA
CBD has the potential to influence many of the key pathways involved in Glioblastoma pathogenesis, from tumor stemness and proliferation to angiogenesis and local invasion. Glioblastoma tumors express CB2 receptors, through which CBD and other cannabinoids are thought to exert their anti-cancer efforts (Ellert-Miklaszewska, Adv Exp Med Biol, 2013). Developing clinical trials to evaluate CBD ...
-
based in USA
Fluorescence in situ hybridization (FISH) testing utilizes the combined strengths of traditional cytogenetics, DNA hybridization and fluorescent microscopy to identify sub-microscopic chromosomal structural rearrangements, variants, and low-frequency abnormalities beyond the limits of classic cytogenetic testing. Our full menu of FISH panels and tests provide physicians with flexible ...
-
Manufactured by Invicro, LLCbased in USA
Prostate cancer is the most common type of cancer (aside from skin) in American men with 13 out of every 100 being diagnosed with the disease during their lifetime.1,2Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is expressed in high levels in prostate cancer cells. Due to its location on the cell surface, PSMA is a popular target for imaging to identify the presence ...
-
based in USA
K2bio’s preclinical CRO services provides full support for in vivo and in vitro demands, and regulatory oversight for pharmaceutical products. Our team will provide customized solutions to ensure the most meaningful and accurate data is ...
-
by OracleBiobased in UNITED KINGDOM
Adding value to Immuno-Oncology studies with Quantitative Digital Pathology. Quantitative Digital Pathology provides deep insights into the tumor microenvironment (TME), a knowledge which is crucial for understanding the mechanism of action of new oncology immunotherapies or for investigating new biomarkers. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you